Journal
MOLECULES
Volume 27, Issue 23, Pages -Publisher
MDPI
DOI: 10.3390/molecules27238562
Keywords
antibiotics; anticoagulants; antivirals; COVID-19; interleukin inhibitors; JAKs inhibitors; immunomodulators; NSAIDs; SARS-CoV-2
Funding
- Italian Ministry of University and Research (MUR) [1062_R13_GREEN]
- PRIN (Progetti di Rilevante Interesse Nazionale) from MUR, Italy [2017M8R7N9_004, 2020KSY3KL_005]
- Project HORIZON EUROPE SEEDS [S17]
Ask authors/readers for more resources
This review provides an overview of the current pharmacological therapies used for the treatment of COVID-19, highlighting the ongoing need for more effective vaccines, therapies, and other solutions.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It caused the highly contagious disease called coronavirus disease 2019 (COVID-19), declared a global pandemic by the World Health Organization (WHO) on 11 March 2020. A great number of studies in the search of new therapies and vaccines have been carried out in these three long years, producing a series of successes; however, the need for more effective vaccines, therapies and other solutions is still being pursued. This review represents a tracking shot of the current pharmacological therapies used for the treatment of COVID-19.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
